Rockbridge Investment Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-23
Closed -$336 465
2023
Q4
$336 Buy
+23
New +$313 ﹤0.01% 630
2022
Q3
Sell
-116
Closed -$3.93K 441
2022
Q2
$3.93K Sell
116
-172
-60% -$6.02K ﹤0.01% 484
2022
Q1
$10.1K Sell
288
-34
-11% -$1.16K ﹤0.01% 507
2021
Q4
$10K Hold
322
﹤0.01% 570
2021
Q3
$11K Sell
322
-15
-4% -$480 ﹤0.01% 513
2021
Q2
$10K Buy
+337
New +$11.1K ﹤0.01% 535

Other funds holding OGN

Rockbridge Investment Management's OGN Position: Q1 2024 in Review

Rockbridge Investment Management sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 23 shares — an estimated $336 sold.

Rockbridge Investment Management first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $11K in Q3 2021. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Rockbridge Investment Management reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • Rockbridge Investment Management sold 23 Organon & Co shares in Q1 2024, an estimated $336.
  • Rockbridge Investment Management first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
  • Rockbridge Investment Management's Organon & Co position peaked at $11K in Q3 2021.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.